Takeda Pharmaceutical Co. Ltd. · TSE:4502
Plump Andrew Stewart sold 19,651 Takeda Pharmaceutical Co. Ltd. shares (Form 4)
Traded Aug 19, 2026 · Filed Aug 21, 2026
On Aug 19, 2026, Plump Andrew Stewart (Director, President, R&D) sold 19,651 Takeda Pharmaceutical Co. Ltd. shares at US$18.49 for US$363K under a trading plan, leaving 261,656 shares. Filed Aug 21, 2026 (Form 4).
- Sold
- 19,651 shares
- Price
- US$18.49
- Value
- US$363K
- Holding after
- 261,656 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, President, R&D
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | American Depositary Shares | Sale | 19,651 | US$18.49 | 261,656 | Indirect |
Source
Related
- Takeda Pharmaceutical Co. Ltd.
- Plump Andrew Stewart
- Takeda Pharmaceutical Co. Ltd. shareholders
- Form 4 · Plump Andrew Stewart · Sep 3, 2026
- Form 4 · Plump Andrew Stewart · Aug 12, 2026
- Form 4 · Plump Andrew Stewart · Jul 6, 2026
- Form 4 · Plump Andrew Stewart · Apr 28, 2026
- Form 4 · Duprey Lauren Rusckowski · Sep 15, 2026
- Form 4 · Greenway Nicola Deidre Petal · Aug 19, 2026
- Form 4 · Shannon Elaine Mary · Aug 12, 2026
- Form 4 · Farajallah Awny Samaan Botros · Aug 12, 2026
- Form 4 · Ibrahim Ramy Riad Ahmed · Aug 12, 2026